What Is Pea Phenylethylamine? Normal vs Optimal Range Explained

PEA is a trace amine produced from phenylalanine by the enzyme aromatic L-amino acid decarboxylase (AADC) and rapidly broken down by monoamine oxidase B (MAOB). Its half-life in the brain is measured in minutes, which means urinary PEA reflects cumulative production over the collection period rather than a momentary snapshot. The CTD maps over 420 gene–chemical interactions for phenylethylamine pathways, confirming PEA's role as a neuromodulator that amplifies dopamine and norepinephrine signaling at synapses. When PEA drops below 0.2 mmol/mol creatinine, it suggests either insufficient phenylalanine substrate, impaired AADC enzyme activity (which also affects serotonin and dopamine synthesis), or excessive MAOB degradation. Low PEA is consistently associated with depression, ADHD-like inattention, and reduced motivation in clinical studies.

Elevated PEA above 1.5 mmol/mol creatinine raises different concerns. Excessively rapid PEA production can overstimulate catecholamine pathways, producing anxiety, sensory overload, and racing thoughts. PubMed indexes over 1,800 publications on phenylethylamine in human neurobiology, establishing PEA as a endogenous compound that modulates the same pathways targeted by amphetamine-class medications—though at much lower intensity. MAOB inhibitors like selegiline directly elevate PEA by blocking its degradation, which contributes to their antidepressant and cognitive-enhancing effects. The organic acids test (OAT) and DUTCH test both measure urinary PEA as a window into dopaminergic tone that standard neurotransmitter panels miss.

Targeting PEA within the 0.2–1.5 mmol/mol creatinine range indicates balanced dopamine pathway function—adequate stimulatory drive for focus, motivation, and mood without the overstimulation that produces anxiety. PEA is particularly valuable as a biomarker because it reflects the upstream enzymatic health of the catecholamine pathway. The same AADC enzyme that produces PEA also converts 5-HTP to serotonin and L-DOPA to dopamine, meaning low PEA often indicates broader neurotransmitter synthesis impairment affecting multiple pathways simultaneously. Vitamin B6 (pyridoxal-5-phosphate) is the required cofactor for AADC, making B6 status one of the first things to investigate when PEA is low.